The Maternal Omega-3 Long-Chain Polyunsaturated Fatty Acid Concentration in Early Pregnancy and Infant Neurodevelopment: The ECLIPSES Study.

"Conflicts of Interest The authors declare no conflicts of interest. The funders played no role in the study’s design, data collection, analysis, manuscript writing, or in the decision to publish."

"The ECLIPSES trial received financial support from the Health Research Fund of the Ministry of Health and Consumption (Madrid, Spain) through grants PI12/02777 and PI17/01754, as well as from the European Union (ERDF/ESF, “A way to make Europe”/“Investing in your future”). "

"The Clinical Research Ethics Committee of the Jordi Gol Institute for Primary Care Research (IDIAP), the Pere Virgili Institute for Health Research (IISPV) (REF.NO. 118/2017, date: 2017), and the Spanish Agency for Medicines and Medical Devices (AEMPS) approved all procedures involving human subjects. Every woman who took part in the study gave her informed permission. Also, this clinical trial was registered at www.clinicaltrialsregister.eu, accessed on 21 May 2013 with EudraCT number 2012-005480-28, and at www.clinicaltrials.gov, accessed on 23 June 2017 with identification number NCT03196882. All participants signed an informed consent form. The study complies with the tenets of the Declaration of Helsinki. Institutional Review Board Statement: This research was registered at both ClinicalTrials.gov (with identification number NCT03196882, approval on 21 May 2013) and the EU Clinical Trials Register (EUCTR-2012-005480-28, approval on 23 June 2017). Approval for this study was obtained from the Ethical Committee of the Jordi Gol Institute for Primary Care Research and the Pere Virgili Institute for Health Research (ref. no. 118/2017, date: 28 September 2017), and it adhered to the principles outlined in the Helsinki Declaration."